IDEXX Laboratories, Inc. IDXX recently expanded its Fecal Dx antigen testing platform with the addition of Cystoisospora — a common intestinal parasite that is the source of diarrhea, weight loss and ...
The rapid diagnostic test provides a comprehensive solution for detecting canine leishmaniosis that impacts one in 10 dogs in endemic regions "In Leishmania-endemic areas globally, where one in 10 ...
Hosted on MSN
Idexx raises 2025 revenue outlook to $4.28B as inVue Dx placements surge and innovation momentum builds
Jonathan J. Mazelsky, CEO, highlighted, "IDEXX delivered a very strong quarter of performance as reflected in solid execution across all key drivers of our strategy." He emphasized rapid adoption of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback